Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT07816575
NA

Comparative Efficacy of Alpha Hydroxy Acids With and Without Nanocarriers Versus Calcipotriol Plus Betamethasone in Treatment of Plaque Psoriasis

Sponsor: Al-Azhar University

View on ClinicalTrials.gov

Summary

The aim of this double blind comparative clinical study is to evaluate the efficacy of AHAs combined with nanocarriers and their use as a non steroidal alternative drug for long term management of plaque psoriasis

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

80

Start Date

2024-03-15

Completion Date

2025-09-10

Last Updated

2026-09-11

Healthy Volunteers

No

Conditions

Interventions

DRUG

Alpha Hydroxy Acids with nanocarriers

Topical Alpha Hydroxy Acids formulated with nanocarriers applied to psoriatic plaques.

DRUG

Alpha Hydroxy Acids only.

Topical Alpha Hydroxy Acids only applied to psoriatic plaques.

DRUG

Calcipotriol plus betamethasone

Topical calcipotriol plus betamethasone ointment applied to psoriatic plaques.

OTHER

Placebo.

Vehicle control / Placebo topical application applied to psoriatic plaques

Locations (1)

Al-Hussien and cairo dermatology Hospital

Cairo, Egypt